Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AstraZeneca Oy
OY
Active
Y-tunnus 0196941-1
Keilaranta 18, 02150
Espoo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1965 · 61 years old
— employees
www.astrazeneca.fi
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
AstraZeneca Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
7404B
5553B
3702B
1851B
0B
2021: 0.0B
0.0B
2021
2022: 0.1B (+21% vs 2021)
0.1B
+21%
2022
2023: 5946B (+11434137% vs 2022)
5946B
+11434137%
2023
2024: not reported
2024
2025: 0B
0B
2025
EBITDA
EUR millions
2.0B
1.5B
1.0B
0.5B
0B
2021: 0.0B
0.0B
2021
2022: 0.0B (0% vs 2021)
0.0B
0%
2022
2023: 1.6B (+160100% vs 2022)
1.6B
+160100%
2023
2024: not reported
2024
2025: 0.0B
0.0B
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
0
—
5 945 802 950
51 917
43 318
Staff expenses
−0
—
−1 187 465 010
−9 160
−7 227
EBITDA
2 432
—
1 601 584
1 208
1 164
Depreciation & amort.
−0
—
−1 084 918
−1
−4
EBIT
2 432
—
516 666
1 206
1 161
Net financials
0
—
826 179
68
1
Profit before tax
3 104
—
44 196 586
1 275
1 162
Tax
792
—
43 287
397
302
Net profit
2 312
—
909 979
877
860
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
44 082
—
38 720
35 363
30 213
Equity
26 278
23 966
22 910
22 000
21 123
Long-term debt
0
—
236 633
1 218
936
Short-term debt
4 441
—
611 614
12 146
8 155
Total debt
17 804
—
15 810
13 363
9 091
Financial ratios
5-year trend
EBITDA margin
>999%
This company
15.8%
Market median
This company
Market median
>999% above market
2021
2025
Equity ratio
59.6%
This company
38.2%
Market median
This company
Market median
56% above market
2021
2025
Return on equity
8.8%
This company
18.4%
Market median
This company
Market median
52% below market
2021
2025
Net profit margin
>999%
This company
8.1%
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0.68×
This company
0.62×
Market median
This company
Market median
10% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on AstraZeneca Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
